{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:20:18Z","timestamp":1784164818848,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Centers for Medicare and Medicaid Services (CMS) created a new reimbursement model \u201cBundled Payment for Care Improvement (BPCI)\u201d which reimburses providers a predetermined payment in advance to cover all possible services rendered within a certain time window. Chordoma and Chondrosarcoma are locally aggressive malignant primary bony tumors. Treatment includes surgical resection and radiotherapy with substantial risk for recurrence which necessitates monitoring and further treatment. We assessed the feasibility of the BPCI model in these neurosurgical diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We selected patients with chordoma\/chondrosarcoma from inpatient admission table using the International Classification of Disease, 9th (ICD-9), and 10th (ICD-10) revision codes. We collected the patients\u2019 demographics and insurance type at the index hospitalization. We recorded the following outcomes length of stay, total payment, discharge disposition, and complications for the index hospitalization. For post-discharge, we collected the 30 days and 3\/6\/12 months inpatient admission, outpatient service, and medication refills. Continuous variables were summarized by means with standard deviations, median with interquartile and full ranges (minimum-maximum); Continuous outcomes were compared by nonparametric Wilcoxson rank-sum test. All tests were 2-sided with a significance level of 0.05. Statistical data analysis was performed in SAS 9.4 (SAS Institute, Inc, Cary, NC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The population size was 2041 patients which included 1412 patients with cranial (group1), 343 patients with a mobile spine (group 2), and 286 patients with sacrococcygeal (group 3) chordoma and chondrosarcoma. For index hospitalization, the median length of stay (days) was 4, 6, and 7 for groups 1, 2, and 3 respectively (P&lt;.001). The mean payments were ($58,130), ($84,854), and ($82,440), for groups 1, 2, and 3 respectively (P=.02). The complication rates were 30%, 35%, and 43% for groups 1, 2, and 3 respectively (P&lt;.001). Twelve months post-discharge, the hospital readmission rates were 44%, 53%, and 65% for groups 1, 2, and 3, respectively (P&lt;.001). The median payments for this period were ($72,294), ($76,827), and ($101,474), for groups 1, 2, and 3, respectively (P &lt;.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The management of craniospinal chordoma and chondrosarcoma is costly and may extend over a prolonged period. The success of BPCI requires a joint effort between insurers and hospitals. Also, it should consider patients\u2019 comorbidities, the complexity of the disease. Finally, the adoptionof quality improvement programs by hospitals can help with cost reduction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-020-01850-w","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T06:22:35Z","timestamp":1597990955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Economics of the Management of Craniospinal Chordoma and Chondrosarcoma and the feasibility of the bundled payment model"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-4749","authenticated-orcid":false,"given":"Zaid","family":"Aljuboori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Ugiliweneza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Andaluz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Boakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"issue":"24","key":"1850_CR1","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1001\/jama.2016.16885","volume":"316","author":"JL Dieleman","year":"2016","unstructured":"Dieleman JL, Baral R, Birger M, Bui AL, Bulchis A, Chapin A, Hamavid H, Horst C, Johnson EK, Joseph J, et al. US spending on personal health care and public health, 1996-2013. JAMA. 2016;316(24):2627\u201346.","journal-title":"JAMA."},{"key":"1850_CR2","first-page":"72","volume-title":"Health system financing","author":"WHO","year":"2010","unstructured":"WHO. Health system financing. Geneva: WHO; 2010. p. 72\u20135."},{"issue":"15","key":"1850_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/archinternmed.2011.212","volume":"171","author":"JS Goodwin","year":"2011","unstructured":"Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011;171(15):1335\u201343.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1850_CR4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1287\/mnsc.2016.2445","volume":"63","author":"EMH Adida","year":"2017","unstructured":"Adida EMH, Nassiri S. Bundled payment vs. fee-for-service: impact of payment scheme on performance. Manag Sci. 2017;63(5):1606\u201324.","journal-title":"Manag Sci"},{"issue":"1","key":"1850_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.nec.2007.09.007","volume":"19","author":"GS McLoughlin","year":"2008","unstructured":"McLoughlin GS, Sciubba DM, Wolinsky JP. Chondroma\/Chondrosarcoma of the spine. Neurosurg Clin N Am. 2008;19(1):57\u201363.","journal-title":"Neurosurg Clin N Am"},{"issue":"1","key":"1850_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1008947301735","volume":"12","author":"ML McMaster","year":"2001","unstructured":"McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001;12(1):1\u201311.","journal-title":"Cancer Causes Control"},{"key":"1850_CR7","unstructured":"Hansen LGCS. Health research data for the real world: the Thomson Reuters MarketScan databases. Truven Health Analytics. 2012."},{"issue":"1","key":"1850_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8\u201327.","journal-title":"Med Care"},{"issue":"11","key":"1850_CR9","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130\u20139.","journal-title":"Med Care"},{"issue":"3","key":"1850_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/jso.23627","volume":"110","author":"AA Parikh","year":"2014","unstructured":"Parikh AA, Robinson J, Zaydfudim VM, Penson D, Whiteside MA. The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer. J Surg Oncol. 2014;110(3):227\u201332.","journal-title":"J Surg Oncol"},{"issue":"2","key":"1850_CR11","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/S1470-2045(11)70337-0","volume":"13","author":"BP Walcott","year":"2012","unstructured":"Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13(2):e69\u201376.","journal-title":"Lancet Oncol"},{"issue":"7","key":"1850_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/1097-0142(20010401)91:7<1201::AID-CNCR1120>3.0.CO;2-W","volume":"91","author":"P Bergh","year":"2001","unstructured":"Bergh P, Gunterberg B, Meis-Kindblom JM, Kindblom LG. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer. 2001;91(7):1201\u201312.","journal-title":"Cancer."},{"key":"1850_CR13","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1016\/j.wneu.2018.11.194","volume":"123","author":"K Omran","year":"2019","unstructured":"Omran K, Abdel-Fattah AS. Posterior extensive circumferential Decompressive reconstructive technique in surgical treatment of upper thoracic spine compressive lesions. World Neurosurg. 2019;123:e501\u20138.","journal-title":"World Neurosurg"},{"issue":"6","key":"1850_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3171\/2011.7.JNS11355","volume":"115","author":"S Di Maio","year":"2011","unstructured":"Di Maio S, Temkin N, Ramanathan D, Sekhar LN. Current comprehensive management of cranial base chordomas: 10-year meta-analysis of observational studies. J Neurosurg. 2011;115(6):1094\u2013105.","journal-title":"J Neurosurg"},{"issue":"1","key":"1850_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00701-009-0535-7","volume":"152","author":"E Ito","year":"2010","unstructured":"Ito E, Saito K, Okada T, Nagatani T, Nagasaka T. Long-term control of clival chordoma with initial aggressive surgical resection and gamma knife radiosurgery for recurrence. Acta Neurochir. 2010;152(1):57\u201367 discussion 67.","journal-title":"Acta Neurochir"},{"issue":"3","key":"1850_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clon.2010.09.011","volume":"23","author":"S Potluri","year":"2011","unstructured":"Potluri S, Jefferies SJ, Jena R, Harris F, Burton KE, Prevost AT, Burnet NG. Residual postoperative tumour volume predicts outcome after high-dose radiotherapy for chordoma and chondrosarcoma of the skull base and spine. Clin Oncol (R Coll Radiol). 2011;23(3):199\u2013208.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1850_CR17","doi-asserted-by":"crossref","unstructured":"Reese JC, Twitchell S, Wilde H, Azab MA, Guan J, Karsy M. Analysis of treatment cost variation among multiple neurosurgical procedures using the value-driven outcomes database. World Neurosurg. 2019.","DOI":"10.1016\/j.wneu.2019.03.010"},{"issue":"1","key":"1850_CR18","doi-asserted-by":"publisher","first-page":"E109","DOI":"10.1093\/neuros\/nyy396","volume":"85","author":"DE Fry","year":"2019","unstructured":"Fry DE, Nedza SM, Pine M, Reband AM, Huang CJ, Pine G. Inpatient and Postdischarge outcomes following elective craniotomy for mass lesions. Neurosurgery. 2019;85(1):E109\u201315.","journal-title":"Neurosurgery."},{"issue":"3","key":"1850_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3171\/2016.2.SPINE15954","volume":"25","author":"D Lau","year":"2016","unstructured":"Lau D, Chan AK, Theologis AA, Chou D, Mummaneni PV, Burch S, Berven S, Deviren V, Ames C. Costs and readmission rates for the resection of primary and metastatic spinal tumors: a comparative analysis of 181 patients. J Neurosurg Spine. 2016;25(3):366\u201378.","journal-title":"J Neurosurg Spine"},{"issue":"5","key":"1850_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3174\/ajnr.A5592","volume":"39","author":"M Killer-Oberpfalzer","year":"2018","unstructured":"Killer-Oberpfalzer M, Kocer N, Griessenauer CJ, Janssen H, Engelhorn T, Holtmannspotter M, Buhk JH, Finkenzeller T, Fesl G, Trenkler J, et al. European multicenter study for the evaluation of a dual-layer flow-diverting stent for treatment of wide-neck intracranial aneurysms: the European flow-redirection intraluminal device study. AJNR Am J Neuroradiol. 2018;39(5):841\u20137.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1850_CR21","doi-asserted-by":"crossref","unstructured":"Turcotte J, Sanford Z, Broda A, Patton C. Centers for Medicare & Medicaid Services Hierarchical Condition Category score as a predictor of readmission and reoperation following elective inpatient spine surgery. J Neurosurg Spine. 2019:1\u20137.","DOI":"10.3171\/2019.3.SPINE1999"},{"issue":"13","key":"1850_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/BRS.0000000000002968","volume":"44","author":"A Dagal","year":"2019","unstructured":"Dagal A, Bellabarba C, Bransford R, Zhang F, Chesnut RM, O'Keefe GE, Wright DR, Dellit TH, Painter I, Souter MJ. Enhanced perioperative Care for Major Spine Surgery. Spine (Phila Pa 1976). 2019;44(13):959\u201366.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1850_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13741-019-0114-2","volume":"8","author":"J Smith","year":"2019","unstructured":"Smith J, Probst S, Calandra C, Davis R, Sugimoto K, Nie L, Gan TJ, Bennett-Guerrero E. Enhanced recovery after surgery (ERAS) program for lumbar spine fusion. Perioper Med (Lond). 2019;8:4.","journal-title":"Perioper Med (Lond)"},{"issue":"3","key":"1850_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-013-1183-6","volume":"114","author":"S Ambekar","year":"2013","unstructured":"Ambekar S, Sharma M, Madhugiri VS, Nanda A. Trends in intracranial meningioma surgery and outcome: a Nationwide inpatient sample database analysis from 2001 to 2010. J Neuro-Oncol. 2013;114(3):299\u2013307.","journal-title":"J Neuro-Oncol"},{"issue":"5","key":"1850_CR25","first-page":"995","volume":"52","author":"FG Barker 2nd","year":"2003","unstructured":"Barker FG 2nd, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS. In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: The effect of hospital and surgeon volume. Neurosurgery. 2003;52(5):995\u20131007 discussion 1007-1009.","journal-title":"Neurosurgery"},{"issue":"1","key":"1850_CR26","first-page":"48","volume":"52","author":"JA Cowan Jr","year":"2003","unstructured":"Cowan JA Jr, Dimick JB, Leveque JC, Thompson BG, Upchurch GR Jr, Hoff JT. The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery. 2003;52(1):48\u201353 discussion 53-44.","journal-title":"Neurosurgery"},{"key":"1850_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4137\/CMO.S10099","volume":"7","author":"P Katonis","year":"2013","unstructured":"Katonis P, Datsis G, Karantanas A, Kampouroglou A, Lianoudakis S, Licoudis S, Papoutsopoulou E, Alpantaki K. Spinal osteosarcoma. Clin Med Insights Oncol. 2013;7:199\u2013208.","journal-title":"Clin Med Insights Oncol"},{"issue":"51","key":"1850_CR28","doi-asserted-by":"publisher","first-page":"e9392","DOI":"10.1097\/MD.0000000000009392","volume":"96","author":"G Wu","year":"2017","unstructured":"Wu G, Liang Q, Liu Y. Primary osteosarcoma of frontal bone: a case report and review of literature. Medicine (Baltimore). 2017;96(51):e9392.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1850_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1590\/S0102-36162012000400007","volume":"47","author":"DG Bellan","year":"2012","unstructured":"Bellan DG, Filho RJ, Garcia JG, de Toledo PM, Maia Viola DC, Schoedl MF, Petrilli AS. Ewing's sarcoma: epidemiology and prognosis for patients treated at the pediatric oncology institute. Iop-Graacc-Unifesp Rev Bras Ortop. 2012;47(4):446\u201350.","journal-title":"Iop-Graacc-Unifesp Rev Bras Ortop"},{"issue":"1","key":"1850_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/1817-1745.97630","volume":"7","author":"CV Gopalakrishnan","year":"2012","unstructured":"Gopalakrishnan CV, Shrivastava A, Easwer HV, Nair S. Primary Ewing\u2019s sarcoma of the spine presenting as acute paraplegia. J Pediatr Neurosci. 2012;7(1):64\u20136.","journal-title":"J Pediatr Neurosci"},{"issue":"S 01","key":"1850_CR31","first-page":"059","volume":"81","author":"Z Aljuboori","year":"2020","unstructured":"Aljuboori Z, Ugiliweneza B, Andaluz N, Boakye M, Williams B. Economics of the treatment of Craniospinal Chordoma and Chondrosarcoma and the feasibility of using the bundled payment model. J Neurol Surg. 2020;81(S 01):059.","journal-title":"J Neurol Surg"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01850-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01850-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01850-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T19:12:19Z","timestamp":1629486739000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01850-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1850"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01850-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21490\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21490\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Administrative permission was not required to access the raw data from United States MarketScan database.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}